Slides on Optimizing Use of Oral HIV PrEP

Consider expert perspectives on approved and guideline-recommended oral HIV PrEP regimens as well as key insights on determining PrEP candidacy and important considerations for specific populations/clinical scenarios, including adolescents, pregnancy/breastfeeding, and transgender individuals.
Darrell H. S. Tan, MD, FRCPC, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 318 KB
Released: August 4, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Gilead Sciences, Inc.

Related Content

Slides from CCO: Discussion of key data and recommendations for choosing ART regimens for older patients with renal impairment or liver disease.

Jonathan Appelbaum, MD, FACP, AAHIVS Jens D. Lundgren, MD, DMSc Released: January 13, 2022

Expert insight on treatment strategies for NASH in patients living with HIV, from Clinical Care Options (CCO)

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: January 10, 2022 Expired: January 9, 2023

From Clinical Care Options (CCO) and Dr. Jürgen K. Rockstroh and Dr. Giada Sebastiani: Recommended approach for screening and diagnosing NASH in patients with HIV.

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: January 10, 2022 Expired: January 9, 2023

Expert commentary by Dr Mark S. Sulkowski on the importance of investigating elevated liver enzymes in patients with HIV, from Clinical Care Options (CCO)

Mark S. Sulkowski, MD Released: January 10, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings